chr16-686871-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_032259.4(WDR24):c.1205C>T(p.Thr402Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,610,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_032259.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WDR24 | NM_032259.4 | c.1205C>T | p.Thr402Met | missense_variant | 3/9 | ENST00000293883.9 | |
WDR24 | XM_047434767.1 | c.974C>T | p.Thr325Met | missense_variant | 3/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WDR24 | ENST00000293883.9 | c.1205C>T | p.Thr402Met | missense_variant | 3/9 | 1 | NM_032259.4 | P1 | |
WDR24 | ENST00000248142.7 | c.1595C>T | p.Thr532Met | missense_variant | 7/13 | 5 | |||
WDR24 | ENST00000647644.1 | c.1427C>T | p.Thr476Met | missense_variant | 4/10 | ||||
WDR24 | ENST00000567014.1 | n.59C>T | non_coding_transcript_exon_variant | 1/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152264Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000111 AC: 27AN: 242942Hom.: 0 AF XY: 0.000113 AC XY: 15AN XY: 132834
GnomAD4 exome AF: 0.0000254 AC: 37AN: 1457660Hom.: 0 Cov.: 32 AF XY: 0.0000207 AC XY: 15AN XY: 725252
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152382Hom.: 0 Cov.: 34 AF XY: 0.0000537 AC XY: 4AN XY: 74514
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at